Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04349267 · ClinicalTrials.gov registry record · Phase 1

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor, sponsored by Bristol-Myers Squibb.

Completed
Registry status
Phase 1
Development phase
44
Enrollment target
8
Study locations

NCT04349267 is a Phase 1 study of Advanced Solid Tumor that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 44 participants, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (77% lower). The trial reports 8 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04349267, a Phase 1 study of Advanced Solid Tumor, has completed, sponsored by Bristol-Myers Squibb.

COMPLETED
Registry status
Phase 1
Development phase
44 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to evaluate BMS-986315 alone and in combination with nivolumab or cetuximab in participants with advanced solid tumors.

Conditions Studied

Advanced Solid Tumor

Interventions

  • BIOLOGICAL nivolumab
  • BIOLOGICAL cetuximab
  • BIOLOGICAL BMS-986315

Study Locations (8)

South Dakota

  • Local Institution - 0028 - Sioux Falls

Tennessee

  • Local Institution - 0001 - Germantown

Alberta

  • Local Institution - 0014 - Edmonton

British Columbia

  • Local Institution - 0011 - Vancouver

Ontario

  • Local Institution - 0004 - Toronto

Quebec

  • Local Institution - 0005 - Montreal

Other

  • Local Institution - 0013 - Ottawa

Mexico City

  • Local Institution - Mexico City

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2020-07-14
Est. Completion 2024-08-22
Phase Phase 1

Sponsor

Bristol-Myers Squibb

1,025 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04349267

The ClinicalTrials.gov registry entry for NCT04349267 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (77% lower). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 3 interventions - of which nivolumab is the first listed.

NCT04349267 reports 8 study locations spanning 8 distinct geographic areas - top geographies include South Dakota, Tennessee, Alberta.

Frequently Asked Questions

What is clinical trial NCT04349267 about?

NCT04349267 is a clinical study titled "Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors". The purpose of this study is to evaluate BMS-986315 alone and in combination with nivolumab or cetuximab in participants with advanced solid tumors.

What is the current status of trial NCT04349267?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2020-07-14. Estimated completion is 2024-08-22.

What conditions does trial NCT04349267 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT04349267?

The interventions under investigation include: nivolumab (BIOLOGICAL), cetuximab (BIOLOGICAL), BMS-986315 (BIOLOGICAL).

Who is sponsoring clinical trial NCT04349267?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04349267 being conducted?

This trial has 8 study locations across South Dakota, Tennessee, Alberta, British Columbia, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

South Dakota

All trials with a study site in South Dakota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.